IndraLab

Statements


KCNK2 inhibits AD. 1 / 1
| 1

reach
"Previous studies have shown that the blockade or the TREK-1 deletion enhances the midbrain 5-HT neuron firing rate, a key parameter predictive of AD efficacy."